SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-009439
Filing Date
2018-05-10
Accepted
2018-05-10 16:11:35
Documents
78
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20180331_10q.htm 10-Q 1188385
2 EXHIBIT 31.1 ex_113137.htm EX-31.1 8617
3 EXHIBIT 31.2 ex_113138.htm EX-31.2 8259
4 EXHIBIT 32.1 ex_113139.htm EX-32.1 4078
5 EXHIBIT 32.2 ex_113140.htm EX-32.2 3991
  Complete submission text file 0001437749-18-009439.txt   7480113

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nby-20180331.xml EX-101.INS 1693557
7 XBRL TAXONOMY EXTENSION SCHEMA nby-20180331.xsd EX-101.SCH 86216
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20180331_cal.xml EX-101.CAL 40331
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20180331_def.xml EX-101.DEF 511004
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20180331_lab.xml EX-101.LAB 449268
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20180331_pre.xml EX-101.PRE 542791
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 18822625
SIC: 2834 Pharmaceutical Preparations